These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 29555442)
21. Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue. Lei C; Davoodi P; Zhan W; Chow PK; Wang CH J Pharm Sci; 2019 May; 108(5):1736-1745. PubMed ID: 30552956 [TBL] [Abstract][Full Text] [Related]
22. An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma. Xu HL; Mao KL; Lu CT; Fan ZL; Yang JJ; Xu J; Chen PP; ZhuGe DL; Shen BX; Jin BH; Xiao J; Zhao YZ Biomaterials; 2016 Nov; 107():44-60. PubMed ID: 27614158 [TBL] [Abstract][Full Text] [Related]
23. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer. He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889 [TBL] [Abstract][Full Text] [Related]
24. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
25. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009 [TBL] [Abstract][Full Text] [Related]
26. RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery. Hao R; Sun B; Yang L; Ma C; Li S Drug Deliv; 2020 Dec; 27(1):772-781. PubMed ID: 32400219 [TBL] [Abstract][Full Text] [Related]
28. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy. Pang L; Zhu Y; Qin J; Zhao W; Wang J Drug Deliv; 2018 Nov; 25(1):1922-1931. PubMed ID: 30465444 [TBL] [Abstract][Full Text] [Related]
29. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy. Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167 [TBL] [Abstract][Full Text] [Related]
30. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide. Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217 [TBL] [Abstract][Full Text] [Related]
32. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700 [TBL] [Abstract][Full Text] [Related]
33. Glioma targeting peptide modified apoferritin nanocage. Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297 [TBL] [Abstract][Full Text] [Related]
34. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related]
35. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. Caban-Toktas S; Sahin A; Lule S; Esendagli G; Vural I; Karlı Oguz K; Soylemezoglu F; Mut M; Dalkara T; Khan M; Capan Y Int J Pharm; 2020 Mar; 578():119076. PubMed ID: 31988035 [TBL] [Abstract][Full Text] [Related]
36. Theranostic gas-generating nanoparticles for targeted ultrasound imaging and treatment of neuroblastoma. Lee J; Min HS; You DG; Kim K; Kwon IC; Rhim T; Lee KY J Control Release; 2016 Feb; 223():197-206. PubMed ID: 26739549 [TBL] [Abstract][Full Text] [Related]
37. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy. Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590 [TBL] [Abstract][Full Text] [Related]
38. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles. Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302 [TBL] [Abstract][Full Text] [Related]